Clinical Trial: Treatment of Hypersensitivity Syndrome (DRESS) With Tegeline® (Human Immunoglobulin)
Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional
Official Title: Treatment of DRESS (Drug Reaction With Eosinophilia and Systemic Symptoms) With Tegeline®
Brief Summary: Efficacy and tolerance of Tegeline® treatment in hypersensitivity syndrome. Immunological study of the T cell index phenotype and functionality in hypersensitivity syndrome.
Detailed Summary:
Sponsor: University Hospital, Rouen
Current Primary Outcome: express healing of visceral attacks, healing of polyadenopathy and body temperature, biological abnormal values normalisation, express healing of cutaneous and mucous diseases immunological study of the T cell index phenotype [ Time Frame: 1 year ]
Original Primary Outcome: express healing of visceral attacks healing of polyadenopathy and body temperature biological abnormal values normalisation express healing of cutanéous and mucous diseases immunological study of the T cell index phenotype [ Time Frame: 1 year ]
Current Secondary Outcome:
Original Secondary Outcome:
Information By: University Hospital, Rouen
Dates:
Date Received: July 20, 2007
Date Started: January 2008
Date Completion:
Last Updated: March 23, 2015
Last Verified: March 2015